NCT01217294

Brief Summary

Pain control after hip replacement surgery is important to ensure patient comfort, allow mobilisation, and aid recovery. The investigators propose a simple and pragmatic study comparing two different anaesthetic techniques in the provision of pain relief after hip surgery. Patients will be randomised to receive either spinal anaesthesia containing morphine or spinal anaesthesia without morphine and an ultrasound guided fascia iliaca nerve block. Although morphine is an effective pain killer, its side effects include itch, urinary retention, nausea and potentially fatal breathing problems. If the nerve block can be shown to provide comparable pain relief to spinal morphine, then morphine could be removed from the spinal injection. This could reduce side effects and improve patient safety. The investigators wish to investigate whether ultrasound guided fascia iliaca plane block provides analgesia which is comparable to that of intrathecal opioid for primary hip arthroplasty in the first 24 hours after hip replacement surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 8, 2010

Completed
7 months until next milestone

Study Start

First participant enrolled

May 1, 2011

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

April 10, 2014

Status Verified

April 1, 2014

Enrollment Period

2.9 years

First QC Date

October 6, 2010

Last Update Submit

April 8, 2014

Conditions

Keywords

anaesthetic techniques, regionalanalgesia, post-operativefascia iliaca compartment blockultrasound guidedsurgery, orthopaedic

Outcome Measures

Primary Outcomes (1)

  • Primary outcome will be post-operative morphine consumption in a 24 hour period as self-administered using a patient controlled analgesia (PCA) pump.

    We hypothesise that ultrasound guided fasca iliaca plane block provides analgesia which is comparable to that of intrathecal opioid for primary hip arthroplasty in the first 24 hours after surgery. This study is powered to detect a difference of 10mg of morphine within a 24 hour period. We would consider a dose of 10mg as being significant clinically.

    24 hours

Secondary Outcomes (8)

  • Pain scores

    48 hours

  • Hypotension

    48 hours

  • post-operative nausea and vomiting

    48 hours

  • Pruritus

    48 hours

  • Sedation

    48 hours

  • +3 more secondary outcomes

Study Arms (2)

spinal morphine, sham block

SHAM COMPARATOR

Spinal anaesthesia with hyperbaric bupivacaine 10 - 15mg as specified by the anaesthetist performing the spinal injection, and with the addition of intrathecal morphine 100 micrograms. Sham ultrasound guided fascia iliaca plane block with saline. Post-operative analgesia with Paracetamol 1g four times daily, and patient controlled analgesia (PCA) with morphine (1mg bolus, 5 minute lockout period)

Procedure: spinal morphine

ultrasound guided fascia iliaca block

ACTIVE COMPARATOR

Spinal anaesthesia with hyperbaric bupivacaine at a dose between 10 and 15mg as deemed appropriate by the anaesthetic doctor performing the spinal injection, no spinal morphine and fascia iliaca plane block using 2mg/kg levobupivacaine diluted to a total of 40ml with sterile saline. Post-operative analgesia with Paracetamol 1g four times daily, and patient controlled analgesia (PCA) with morphine (1mg bolus, 5 minute lockout period)

Procedure: ultrasound guided fascia iliaca block

Interventions

Spinal anaesthesia with hyperbaric bupivacaine at a dose between 10 and 15mg as deemed appropriate by the anaesthetic doctor performing the spinal injection, no spinal morphine and ultrasound guided fascia iliaca plane block using 2mg/kg levobupivacaine diluted to a total of 40ml with sterile saline.

ultrasound guided fascia iliaca block

Spinal anaesthesia with hyperbaric bupivacaine 10 - 15mg as deemed appropriate by the anaesthetists performing the spinal injection, and with the addition of intrathecal morphine 100 micrograms. Sham fascia iliaca plane injection with saline.

spinal morphine, sham block

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English-speaking
  • Competent to give consent
  • ASA physical status I - III
  • years of age, inclusive
  • kg, inclusive
  • Scheduled for unilateral primary hip arthroplasty

You may not qualify if:

  • Contraindications to fascia iliaca plane block
  • Contraindication to spinal anaesthesia
  • Coagulopathy, malignancy or infection in the inguinal area
  • Patient preference for general anaesthesia
  • Allergy to opioids
  • Significant peripheral neuropathy or neurologic disorder affecting the lower extremity
  • Pregnancy
  • History of alcohol or drug dependency / abuse
  • History of long term opioid intake
  • History of significant psychiatric conditions that may affect patient assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glasgow Royal Infirmary

Glasgow, Scotland, G312HT, United Kingdom

Location

Related Publications (1)

  • Kearns RJ, Macfarlane AJ, Anderson KJ, Kinsella J. Intrathecal opioid versus ultrasound guided fascia iliaca plane block for analgesia after primary hip arthroplasty: study protocol for a randomised, blinded, noninferiority controlled trial. Trials. 2011 Feb 21;12:51. doi: 10.1186/1745-6215-12-51.

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • John Kinsella, MBBS MD

    University Section of Anaesthesia, Glasgow University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
co-investigator

Study Record Dates

First Submitted

October 6, 2010

First Posted

October 8, 2010

Study Start

May 1, 2011

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

April 10, 2014

Record last verified: 2014-04

Locations